# Progress Note 02 — Focused Visit (Intermediate follow-up)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Audie Leon Murphy (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ET007-SYN
- Date: 2026-08-11
- Fictional facility: St. Posthumous Health Center
- Fictional author: Elena Marquez, MD
- Calendar frame: modern shifted

- Visit type: Focused Visit (Intermediate follow-up)

## Chief complaint

Six-week PTSD and insomnia follow-up. **S**

## History of present illness

Mr. Murphy returns six weeks after his intake visit for post-traumatic stress disorder and chronic insomnia. He has attended five weekly sessions of Cognitive Processing Therapy with Dr. Lee and completes the practice assignments between sessions; Dr. Lee's consultation report arrived today. His nightmares have fallen from most nights to two or three nights a week. He uses the agreed sleep routine on five to six nights a week and now falls asleep in about 30 minutes instead of more than an hour, although he still wakes once or twice on most nights. He startles less easily and concentrates better at work, and his mood is better. He has had no thoughts of suicide or self-harm since the intake visit. He carries his safety plan, has the 988 Suicide & Crisis Lifeline saved in his phone, and reports that the lethal-means steps agreed at intake remain in place. He drinks no alcohol, uses no cannabis or other drugs, and takes no medicines or sleep aids. No one has noticed loud snoring or pauses in his breathing, and he is not sleepy during the day. **S**

| Element | Detail |
|---|---|
| Interval change | Fewer nightmares, quicker sleep onset, better concentration and mood |
| Nightmares | Two or three nights a week, down from most nights |
| Sleep | Asleep in about 30 minutes; wakes once or twice most nights; routine used five to six nights a week |
| Treatment engagement | Five Cognitive Processing Therapy sessions; practice assignments completed |
| Safety | No suicidal thoughts, intent, or plan since intake; safety plan in use |
| Substances | No alcohol, cannabis, other drugs, or sleep aids |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Energy improving; no weight change of note |
| Respiratory | Negative | No loud snoring or witnessed pauses in breathing |
| Cardiovascular | Negative | No chest pain or daytime palpitations |
| Neurological | Negative | No dizziness or daytime sleepiness |
| Psychiatric | Positive | Nightmares two or three nights a week; mood improved; no suicidal thoughts |

5 systems reviewed. **S**

## Current medications

- No current medications. **S**

## Allergies

- No known allergy **S**

## Objective

BP 128/82 mmHg; pulse 74 bpm; respirations 16/min; temperature 36.7 °C; oxygen saturation 98% on room air; weight 74.2 kg; BMI 27.3 kg/m². All vital signs are synthetic.

PTSD PCL-5 score: 31; PHQ-9 total score: 7. All results are synthetic.

## Change since baseline

- PTSD PCL-5 score: 42 at baseline, 31 at this visit **S**
- PHQ-9 total score: 11 at baseline, 7 at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| General | Well groomed, relaxed in the waiting room, on time |
| Mental status: appearance and behavior | Cooperative with good eye contact; briefly restless when describing nightmares |
| Mental status: speech | Normal rate, volume, and rhythm |
| Mental status: mood and affect | Mood "better than in June"; affect mildly anxious, reactive, and less constricted than at intake |
| Mental status: thought process and content | Linear and goal directed; no suicidal or homicidal ideation, intent, or plan; no delusions |
| Mental status: perception | No hallucinations; no dissociation during the visit |
| Mental status: cognition | Alert and fully oriented; attention and recall intact in conversation |
| Mental status: insight and judgment | Good |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Post-traumatic stress disorder, improving with Cognitive Processing Therapy** (F43.10). PCL-5 fell from 42 to 31, an 11-point drop that exceeds the 10 points usually taken as a clinically meaningful change. A score of 31 is still at the edge of the 31 to 33 range that suggests probable PTSD, so the full course is needed. Dr. Lee's evaluation confirms the diagnosis. **S**
   - Complete the Cognitive Processing Therapy course with Dr. Lee, aiming for at least eight sessions by the twelve-week review.
   - No PTSD medication, in line with his preference and Dr. Lee's advice; revisit only if the response stalls.
   - Repeat the PCL-5 and PHQ-9 at the twelve-week review.
2. **Depressive symptoms**. PHQ-9 fell from 11 to 7. Dr. Lee's interview today found that the low mood, poor sleep, and poor concentration are part of the PTSD, with no separate major depressive episode and no history of mania or hypomania. **S**
   - No separate depression treatment.
   - PHQ-9 continues at each review alongside the PCL-5.
3. **Chronic insomnia, improving** (G47.00). Sleep onset about 30 minutes and nightmares two or three nights a week, with the sleep routine used on five to six nights a week, which meets the six-week sleep goal. No symptoms of sleep apnea. **S**
   - Continue the sleep routine, stimulus control, and a fixed wake time.
   - No sleep medication, and no over-the-counter sedating sleep aids.
   - Offer cognitive behavioral therapy for insomnia if the insomnia persists after the trauma-focused course.
4. **Suicide risk review**. No suicidal ideation, intent, plan, or preparatory behavior since intake on a structured since-last-visit screen. Protective factors are unchanged: engagement in treatment, family and peer supports, and purposeful work and service identity. Acute risk remains low and outpatient care remains appropriate. **S**
   - Safety plan reviewed with him and unchanged; the lethal-means steps from intake remain in place.
   - Crisis resources reconfirmed, including the 988 Suicide & Crisis Lifeline (press 1 for the Veterans Crisis Line).

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Survey | PCL-5 | Baseline, then at set intervals during treatment (care plan: six and twelve weeks) | Completed today | 31, down 11 points from 42 at intake |
| Survey | PHQ-9 | Baseline; at least monthly during active treatment; periodically in recovery | Completed today | 7, down from 11 at intake |
| Survey | PHQ-9 recheck about four weeks after a baseline score of 10 or more | Monthly during active treatment | Deferred | Not done. The care plan set checks at six and twelve weeks, so the intake score of 11 waited six weeks instead of about four, a deviation from the CMID schedule. Today's score of 7 shows no harm resulted, and Dr. Lee's interview today found no separate depressive disorder, so the PHQ-9 now follows the PCL-5 schedule |
| Referral | Behavioral health consultation and diagnostic evaluation | Once, at diagnosis | Completed today | Dr. Lee's report received today: PTSD confirmed; no separate major depressive episode and no history of mania or hypomania, so a bipolar screen (Mood Disorder Questionnaire) is not needed |
| Referral | Trauma-focused psychotherapy (Cognitive Processing Therapy) | Weekly course of about 12 sessions | Up to date | Five sessions attended; on track for the goal of eight by the twelve-week review |
| Survey | Suicide risk reassessment (C-SSRS screener, since last visit) | Every visit during active treatment | Completed today | Negative: no ideation, intent, plan, or behavior since intake |
| Self-management | Safety plan, lethal-means steps, and crisis resources | Every visit | Completed today | Reviewed and unchanged; 988 Suicide & Crisis Lifeline reconfirmed |
| Survey | Alcohol and other substance use | At intake and during treatment | Completed today | None, consistent with the intake social history |
| Self-management | Sleep diary and agreed sleep routine | Every visit | Completed today | Routine used five to six nights a week; sleep onset about 30 minutes; six-week goal met |
| Survey | Obstructive sleep apnea symptom screen | At the insomnia assessment | Completed today | Not documented at the intake visit, a gap in the insomnia assessment; done today: no snoring, witnessed apneas, or daytime sleepiness and BMI 27.3, so sleep testing is not indicated |
| Medication safety | PTSD medication and sedative-hypnotics | If psychotherapy is declined or the response stalls | Not indicated | He chose trauma-focused psychotherapy first and is responding. No benzodiazepines, which the PTSD guideline advises against, and no sleep medicines |
| Examination | Mental status examination, vital signs, and weight | Every visit | Completed today | Affect brighter and less constricted; BP 128/82 mmHg; weight 74.2 kg |
| Laboratory | Laboratory tests | Only for medication monitoring or a suspected medical cause | Not indicated | No medicines; neither protocol calls for routine laboratory tests |

## Goal progress

- Reduce PCL-5 score from 42 to 27 or lower by the twelve-week review. In progress; target 2026-09-30. **S**
- Complete at least eight Cognitive Processing Therapy sessions by the twelve-week review. In progress; target 2026-09-30. **S**
- Use the agreed sleep routine on at least five nights each week by the six-week review. Outcome by 2026-08-11: Patient-reported use on five to six nights each week. **S**

## Guideline basis

- VA/DoD Clinical Practice Guideline for Management of Posttraumatic Stress Disorder and Acute Stress Disorder (2023), United States Department of Veterans Affairs and Department of Defense
- VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024), United States Department of Veterans Affairs and Department of Defense
- VA/DoD Clinical Practice Guideline for Management of Chronic Insomnia Disorder and Obstructive Sleep Apnea (2025), United States Department of Veterans Affairs and Department of Defense
- CMID: Clinical Monitoring Intelligence Database, depression monograph (2026), Aether Forge

## Follow-up

- Cognitive Processing Therapy continues weekly with Dr. Lee. Twelve-week review with the PCL-5 and PHQ-9. Use the safety plan and call the 988 Suicide & Crisis Lifeline (press 1) at any time if needed. **S**
- Next scheduled visit 2026-09-30: three-month care-plan review. **S**
